Author + information
- Received May 31, 2013
- Accepted June 25, 2013
- Published online June 17, 2014.
- Shuangbo Liu, MD∗,
- David Horne, MD†,
- Darren H. Freed, MD, PhD†,
- Siuchan Sookhoo, MD‡,
- Jacek Strzelczyk, MD‡,
- Amir Ravandi, MD, PhD∗,‡ and
- Davinder S. Jassal, MD∗,‡,§
- ∗Section of Cardiology, Department of Internal Medicine, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
- †Section of Cardiac Surgery, Department of Surgery, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
- ‡Department of Radiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
- §Institute of Cardiovascular Sciences, St. Boniface Research Centre, University of Manitoba, Winnipeg, Manitoba, Canada
A 50-year-old man presented with difficult-to-control hypertension. In the work-up for secondary causes of hypertension, the patient was found to have elevated levels of normetanephrine. Computed tomography of the chest confirmed a soft tissue mass located superior to the left atrium (A) with uptake on iodine-131-meta-iodobenzylguanidine scanning. Coronal T1-weighted and axial T2-weighted cardiac magnetic resonance confirmed a 5.1 × 3.7 cm mass that was hyperintense on T2 imaging (B and C). Coronary angiography demonstrated a large vessel arising from the proximal right coronary artery feeding the cardiac mass (D, Online Video 1) that was successfully coiled before surgical resection to reduce the risk of intra-operative bleeding (E, Online Video 2). After appropriate alpha- and beta-blockade therapy, the patient had a 5 × 7-cm tumor with visible feeding vessels (arrows) removed under cardiopulmonary bypass, consistent with a cardiac pheochromocytoma (F).
- Received May 31, 2013.
- Accepted June 25, 2013.
- 2014 American College of Cardiology Foundation